NEXGEL, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NEXGEL, INC. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $285.00K, a 54.03% decline year-over-year.
- NEXGEL, INC. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $395.00K, a 132.35% increase year-over-year.
- NEXGEL, INC. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $375.00K.
- NEXGEL, INC. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $620.00K.
- NEXGEL, INC. stock issued during period, value, new issues for fiscal 2021 was $13.47M, a 883.28% increase from fiscal 2020.
- NEXGEL, INC. stock issued during period, value, new issues for fiscal 2020 was $1.37M, a 103.57% increase from fiscal 2019.
- NEXGEL, INC. stock issued during period, value, new issues for fiscal 2019 was $673.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2021-12-31 | $13.47M 10-K · filed 2023-03-28 | |
| 2021-03-31 | $285.00K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $1.37M 10-K · filed 2022-03-21 | |
| 2020-09-30 | $395.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $375.00K 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $620.00K 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $673.00K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $170.00K 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |